In order to achieve an oncological margin during limb salvage surgery for tumours around the hip, part or the entire hip joint is frequently sacrificed. Hip arthroplasty restores a functional extremity and achieves limb salvage. Currently there is a paucity of data concerning the late complications, long-term survival, and the risks of re-revision following aseptic revision of a total hip arthroplasty (THA) performed following an oncological resection.
Methods
We identified 78 patients who underwent aseptic revision of a THA which was performed for an oncological process involving the hip from 1972 to 2006. All patients had a minimum 5 years of follow-up with a mean of 13 years. Outcomes were compared to 1,378 patients undergoing aseptic revision of a THA that was performed for a diagnosis of osteoarthritis.
Results
The mean 5-, 10-, 15-, and 20-year re-revision-free survival for an oncologic process of the hip was 100%, 85%, 69%, and 57%. Within this cohort, younger patients were at an increased risk of revision surgery. There was no difference in survivorship of the revision implant at any of the aforementioned time points between the oncologic and osteoarthritis cohorts. Patients with an oncologic diagnosis had a higher rate of dislocations, component wear, and loosening compared to the osteoarthritis group.
Conclusion
Late complications following revision surgery of THA performed for an oncologic resection are common. The results of this study provide information for counselling patients on implant survivorship and complications following aseptic revision THA after index surgery for an oncologic indication.
SchneiderbauerMMvon KnochMSchleckCDHarmsenWSSimFHScullySPPatient survival after hip arthroplasty for metastatic disease of the hip.J Bone Joint Surg Am200486(8):1684–1689
2.
MenendezLRAhlmannERKermaniCGothaHEndoprosthetic reconstruction for neoplasms of the proximal femur.Clin Orthop Relat Res2006;450(450):46–51
3.
SimonMAAschlimanMAThomasNMankinHJLimb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur.J Bone Joint Surg Am1986;68(9): 1331–1337
4.
GoorinAMSchwartzentruberDJDevidasMet al;Pediatric Oncology Group Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol2003;21(8):1574–1580
5.
BielackSSKempf-BielackBDellingGPrognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.J Clin Oncol2002;20(3):776–790
6.
GrossAEMcKeeNHPritzkerKPLangerFReconstruction of skeletal deficits at the knee. A comprehensive osteochondral transplant program Clin Orthop Relat Res1983;174:96–106
7.
FoxEJHauMAGebhardtMCHornicekFJTomfordWWMankinHJLong-term followup of proximal femoral allografts.Clin Orthop Relat Res2002;397106–113
8.
ChenWMChenTHHuangCKChiangCCLoWHTreatment of malignant bone tumours by extracorporeally irradiated autograft-prosthetic composite arthroplasty.J Bone Joint Surg Br2002;84(8):1156–1161
9.
UnwinPSCannonSRGrimerRJKempHBSneathRSWalkerPSAseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb.J Bone Joint Surg Br1996;78(1):5–13
10.
DonatiDZavattaMGozziEGiacominiSCampanacciLMercuriMModular prosthetic replacement of the proximal femur after resection of a bone tumour.J Bone Joint Surg Br2001;83-B(8):1156–1160
PotterBKChowVEAdamsSCLetsonGDTempleHTEndoprosthetic proximal femur replacement: metastatic versus primary tumors.Surg Oncol2009;18(4):343–349
13.
JeysLMKulkarniAGrimerRJCarterSRTillmanRMAbuduAEndoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis.J Bone Joint Surg Am2008;90(6):1265–1271
14.
DobbsHSScalesJTWilsonJNKempHBBurrowsHJSneathRSEndoprosthetic replacement of the proximal femur and acetabulum. A survival analysis J Bone Joint Surg Br1981;63(2): 219–224
15.
ChandrasekarCRGrimerRJCarterSRTillmanRMAbuduABuckleyLModular endoprosthetic replacement for tumours of the proximal femur.J Bone Joint Surg Br2009;91(1):108–112
16.
GrimerRJCarterSRPynsentPBThe cost-effectiveness of limb salvage for bone tumours.J Bone Joint Surg Br1997;79(4):558–561
17.
JeysLMGrimerRJCarterSRTillmanRMAbuduAPost operative infection and increased survival in osteosarcoma patients: are they associated?Ann Surg Oncol2007;14(10):2887–2895
18.
DamronTASimFHSurgical treatment for metastatic disease of the pelvis and the proximal end of the femur.Instr Course Lect2000;49461–470
19.
HendersonERGroundlandJSPalaEFailure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review.J Bone Joint Surg Am2011;93(5):418–429
20.
ShinDSWeberKLChaoEYAnKNSimFHReoperation for failed prosthetic replacement used for limb salvage.Clin Orthop Relat Res1999;358:53–63
21.
HsuRWSimFHChaoEYReoperation results after segmental prosthetic replacement of bone and joint for limb salvage.J Arthroplasty1999;14(5):519–526
22.
McGroryBJMorreyBFRandJAIlstrupDMMcGroryBJMorreyBFRandJAIlstrupDMCorrelation of patient questionnaire responses and physician history in grading clinical outcome following hip and knee arthroplasty.J Arthroplasty1996;11(1):47–57
23.
RefaatYGunnoeJHornicekFJMankinHJComparison of quality of life after amputation or limb salvage.Clin Orthop Relat Res2002;397298–305
24.
HorowitzSMGlasserDBLaneJMHealeyJHProsthetic and extremity survivorship after limb salvage for sarcoma.How long do the reconstructions last? Clin Orthop Relat Res1993293:280–286
25.
ShehadehANoveauJMalawerMHenshawRLate complications and survival of endoprosthetic reconstruction after resection of bone tumors.Clin Orthop Relat Res2010;468(11): 2885–2895
26.
StrömbergCNHerbertsPAhnfeltLStrömbergCNHerbertsPAhnfeltLRevision total hip arthroplasty in patients younger than 55 years old.J Arthroplasty1988;3(1):47–59
27.
StrömbergCNHerbertsPStrömbergCNHerbertsPCemented revision total hip arthroplasties in patients younger than 55 years old.J Arthroplasty1996;11(5):489–499
28.
AdelaniMACrookKBarrackRLMaloneyWJClohisyJCWhat is the prognosis of revision total hip arthroplasty in patients 55 years and younger?Clin Orthop Relat Res2014;472(5):1518–1525
29.
HamiltonWGMcAuleyJPTabaraeeEEnghCASrThe outcome of rerevision of an extensively porous-coated stem with another extensively porous-coated stem.J Arthroplasty2008;23(2):170–174
30.
OngKLLauESuggsJKurtzSMManleyMTRisk of subsequent revision after primary and revision total joint arthroplasty.Clin Orthop Relat Res2010;468(11):3070–3076
31.
McLaughlinJRHarrisWHRevision of the femoral component of a total hip arthroplasty with the calcar-replacement femoral component. Results after a mean of 10.8 years postoperatively J Bone Joint Surg Am1996;78(3):331–339
32.
DyCJBozicKJPanTJWrightTMPadgettDELymanSRisk factors for early revision after total hip arthroplasty.Arthritis Care Res (Hoboken)2014;66(6):907–915
33.
SantaguidaPLHawkerGAHudakPLPatient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review.Can J Surg2008;51(6):428–436
34.
HavelinLIEspehaugBVollsetSEEngesaeterLBEarly failures among 14,009 cemented and 1,326 uncemented prostheses for primary coxarthrosis. The Norwegian Arthroplasty Register, 1987-1992 Acta Orthop Scand1994;65(1):1–6
35.
MalchauHHerbertsPEislerTGarellickGSödermanPThe Swedish Total Hip Replacement Register.J Bone Joint Surg Am2002;84-ASuppl 2:2–20
36.
DorrLDTakeiGKConatyJPTotal hip arthroplasties in patients less than forty-five years old.J Bone Joint Surg Am1983;65(4): 474–479
37.
BroosPFourneauIHost factors that affect outcome of total hip arthroplasty.Lancet2000;355(9214):1479–1480
38.
MeyersPAHellerGHealeyJChemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.J Clin Oncol1992;10(1):5–15
39.
BerbariEFHanssenADDuffyMCRisk factors for prosthetic joint infection: case-control study.Clin Infect Dis1998;27(5):1247–1254
40.
JeysLMGrimerRJCarterSRTillmanRMPeriprosthetic infection in patients treated for an orthopaedic oncological condition.J Bone Joint Surg Am2005;87(4):842–849
41.
HanssenADRandJAEvaluation and treatment of infection at the site of a total hip or knee arthroplasty.Instr Course Lect1999;48111–122
42.
MorrisCDSepkowitzKFonshellCProspective identification of risk factors for wound infection after lower extremity oncologic surgery.Ann Surg Oncol2003;10(7):778–782
43.
VelascoEThulerLCMartinsCADiasLMGonçalvesVMRisk index for prediction of surgical site infection after oncology operations.Am J Infect Control1998;26(3):217–223
44.
BabisGCSakellariouVIO'ConnorMIHanssenADSimFHProximal femoral allograft-prosthesis composites in revision hip replacement: a 12-year follow-up study.J Bone Joint Surg Br2010;92(3):349–355
45.
BickelsJMellerIHenshawRMMalawerMMReconstruction of hip stability after proximal and total femur resections.Clin Orthop Relat Res2000;375218–230
46.
MastersonELFerraciniRGriffinAMWunderJSBellRSCapsular replacement with synthetic mesh.J Arthroplasty199813(8):860–866
